Australia is carefully awaiting the arrival of retatrutide, a novel dual GIP and GLP-1 receptor agonist that's generating significant buzz in the global weight management landscape. Developed by Novo Nordisk, this https://qasimcssq959580.ourabilitywiki.com/11053383/retatrutide_australia_a_potential_breakthrough_for_losing_weight